Expectations are growing for the Yoon Seok-yeol administration's policy to quickly register and expand benefits for ultra-high-priced medicines such as anticancer drugs and rare incurable disease drugs. This is the effect of Yoon Seok-yeol, the elected president of the People's Power, making a pledge to quickly register severe diseases and rare cancers and expand health insurance to reduce the burden on patients and insurers.

On the 15th, pharmaceutical companies and patient groups are paying attention to the trend of changes in health insurance policies for rare and intractable diseases that have obtained domestic marketing permits. Attention is focusing on whether cases in which health insurance registra